Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Tranylcypromine price?How could the expiration of bedaquiline's patent impact global accessibility?When can we expect generic sugammadex to be commercially available in the us?Loseasonique generic?Pfizer the originator company of viagra faces revenue loss as generics enter the market?
See the DrugPatentWatch profile for Revlimid
Revlimid is the brand (trade) name for lenalidomide.
Lenalidomide is an immunomodulatory drug used in multiple myeloma and certain related blood cancers (the exact approved uses depend on the country and specific prescribing guidance).
Revlimid is marketed by Celgene (now part of Bristol Myers Squibb).
No. Lenalidomide is also available under other brand and generic formulations in different markets, but Revlimid specifically refers to the branded form. Sources: 1. DrugPatentWatch – Revlimid (lenalidomide)
Other Questions About Revlimid :